Proper Name: Alpha1-Proteinase Inhibitor (Human)
Tradename: ARALAST NP
Manufacturer: Baxalta US Inc.
- Chronic replacement therapy in patients with A1PI deficiency
- December 20, 2022 Approval Letter - ARALAST NP
- Supporting Documents older than three years - Aralast NP
- FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.